▶ 調査レポート

世界の経口抗糖尿病薬市場:専門的調査

• 英文タイトル:Global Oral Anti-Diabetic Drug Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の経口抗糖尿病薬市場:専門的調査 / Global Oral Anti-Diabetic Drug Market Professional Survey Report 2019 / QYR9ST12353資料のイメージです。• レポートコード:QYR9ST12353
• 出版社/出版日:QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートは、経口抗糖尿病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリメピリド、グリクラジド、グリブリド、その他に、用途別には、病院、研究機関にセグメント区分し、経口抗糖尿病薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・経口抗糖尿病薬の世界市場概要
・経口抗糖尿病薬の製造コスト構成分析
・経口抗糖尿病薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・経口抗糖尿病薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・経口抗糖尿病薬のセグメント分析(種類別)
(グリメピリド、グリクラジド、グリブリド、その他)
・経口抗糖尿病薬のセグメント分析(用途別)
(病院、研究機関)
・経口抗糖尿病薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Takeda、Pfizer、Eli Lilly、Janssen Pharmaceuticals、Astellas、Boehringer Ingelheim、Merck And Co.、AstraZeneca、Bristol Myers Squibb、Novartis、Sanofi、Abbott、Biocon)
・経口抗糖尿病薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...

Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
The global Oral Anti-Diabetic Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oral Anti-Diabetic Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Anti-Diabetic Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oral Anti-Diabetic Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oral Anti-Diabetic Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Takeda
Pfizer
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
Merck And Co.
AstraZeneca
Bristol Myers Squibb
Novartis
Sanofi
Abbott
Biocon

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Glimepiride
Gliclazide
Glyburide
Others

Segment by Application
Hospital
Research Institual

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Oral Anti-Diabetic Drug
1.1 Definition of Oral Anti-Diabetic Drug
1.2 Oral Anti-Diabetic Drug Segment by Type
1.2.1 Global Oral Anti-Diabetic Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Glimepiride
1.2.3 Gliclazide
1.2.4 Glyburide
1.2.5 Others
1.3 Oral Anti-Diabetic Drug Segment by Applications
1.3.1 Global Oral Anti-Diabetic Drug Consumption Comparison by Applications (2014-2025)
1.5.2 Hospital
1.5.3 Research Institual
1.4 Global Oral Anti-Diabetic Drug Overall Market
1.4.1 Global Oral Anti-Diabetic Drug Revenue (2014-2025)
1.4.2 Global Oral Anti-Diabetic Drug Production (2014-2025)
1.4.3 North America Oral Anti-Diabetic Drug Status and Prospect (2014-2025)
1.4.4 Europe Oral Anti-Diabetic Drug Status and Prospect (2014-2025)
1.4.5 China Oral Anti-Diabetic Drug Status and Prospect (2014-2025)
1.4.6 Japan Oral Anti-Diabetic Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oral Anti-Diabetic Drug
2.3 Manufacturing Process Analysis of Oral Anti-Diabetic Drug
2.4 Industry Chain Structure of Oral Anti-Diabetic Drug

3 Development and Manufacturing Plants Analysis of Oral Anti-Diabetic Drug
3.1 Capacity and Commercial Production Date
3.2 Global Oral Anti-Diabetic Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Oral Anti-Diabetic Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Oral Anti-Diabetic Drug Production and Capacity Analysis
4.2 Oral Anti-Diabetic Drug Revenue Analysis
4.3 Oral Anti-Diabetic Drug Price Analysis
4.4 Market Concentration Degree

5 Oral Anti-Diabetic Drug Regional Market Analysis
5.1 Oral Anti-Diabetic Drug Production by Regions
5.1.1 Global Oral Anti-Diabetic Drug Production by Regions
5.1.2 Global Oral Anti-Diabetic Drug Revenue by Regions
5.2 Oral Anti-Diabetic Drug Consumption by Regions
5.3 North America Oral Anti-Diabetic Drug Market Analysis
5.3.1 North America Oral Anti-Diabetic Drug Production
5.3.2 North America Oral Anti-Diabetic Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Oral Anti-Diabetic Drug Import and Export
5.4 Europe Oral Anti-Diabetic Drug Market Analysis
5.4.1 Europe Oral Anti-Diabetic Drug Production
5.4.2 Europe Oral Anti-Diabetic Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Oral Anti-Diabetic Drug Import and Export
5.5 China Oral Anti-Diabetic Drug Market Analysis
5.5.1 China Oral Anti-Diabetic Drug Production
5.5.2 China Oral Anti-Diabetic Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Oral Anti-Diabetic Drug Import and Export
5.6 Japan Oral Anti-Diabetic Drug Market Analysis
5.6.1 Japan Oral Anti-Diabetic Drug Production
5.6.2 Japan Oral Anti-Diabetic Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Oral Anti-Diabetic Drug Import and Export

6 Oral Anti-Diabetic Drug Segment Market Analysis (by Type)
6.1 Global Oral Anti-Diabetic Drug Production by Type
6.2 Global Oral Anti-Diabetic Drug Revenue by Type
6.3 Oral Anti-Diabetic Drug Price by Type

7 Oral Anti-Diabetic Drug Segment Market Analysis (by Application)
7.1 Global Oral Anti-Diabetic Drug Consumption by Application
7.2 Global Oral Anti-Diabetic Drug Consumption Market Share by Application (2014-2019)

8 Oral Anti-Diabetic Drug Major Manufacturers Analysis
8.1 Takeda
8.1.1 Takeda Oral Anti-Diabetic Drug Production Sites and Area Served
8.1.2 Takeda Product Introduction, Application and Specification
8.1.3 Takeda Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Oral Anti-Diabetic Drug Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lilly
8.3.1 Eli Lilly Oral Anti-Diabetic Drug Production Sites and Area Served
8.3.2 Eli Lilly Product Introduction, Application and Specification
8.3.3 Eli Lilly Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Janssen Pharmaceuticals
8.4.1 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production Sites and Area Served
8.4.2 Janssen Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Astellas
8.5.1 Astellas Oral Anti-Diabetic Drug Production Sites and Area Served
8.5.2 Astellas Product Introduction, Application and Specification
8.5.3 Astellas Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Boehringer Ingelheim
8.6.1 Boehringer Ingelheim Oral Anti-Diabetic Drug Production Sites and Area Served
8.6.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Merck And Co.
8.7.1 Merck And Co. Oral Anti-Diabetic Drug Production Sites and Area Served
8.7.2 Merck And Co. Product Introduction, Application and Specification
8.7.3 Merck And Co. Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 AstraZeneca
8.8.1 AstraZeneca Oral Anti-Diabetic Drug Production Sites and Area Served
8.8.2 AstraZeneca Product Introduction, Application and Specification
8.8.3 AstraZeneca Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Bristol Myers Squibb
8.9.1 Bristol Myers Squibb Oral Anti-Diabetic Drug Production Sites and Area Served
8.9.2 Bristol Myers Squibb Product Introduction, Application and Specification
8.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novartis
8.10.1 Novartis Oral Anti-Diabetic Drug Production Sites and Area Served
8.10.2 Novartis Product Introduction, Application and Specification
8.10.3 Novartis Oral Anti-Diabetic Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Sanofi
8.12 Abbott
8.13 Biocon

9 Development Trend of Analysis of Oral Anti-Diabetic Drug Market
9.1 Global Oral Anti-Diabetic Drug Market Trend Analysis
9.1.1 Global Oral Anti-Diabetic Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Oral Anti-Diabetic Drug Regional Market Trend
9.2.1 North America Oral Anti-Diabetic Drug Forecast 2019-2025
9.2.2 Europe Oral Anti-Diabetic Drug Forecast 2019-2025
9.2.3 China Oral Anti-Diabetic Drug Forecast 2019-2025
9.2.4 Japan Oral Anti-Diabetic Drug Forecast 2019-2025
9.3 Oral Anti-Diabetic Drug Market Trend (Product Type)
9.4 Oral Anti-Diabetic Drug Market Trend (Application)

10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Oral Anti-Diabetic Drug Distributors List
10.3 Oral Anti-Diabetic Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Oral Anti-Diabetic Drug
Table Global Oral Anti-Diabetic Drug Production (K Tons) Growth Rate Comparison by Types (2014-2025)
Figure Global Oral Anti-Diabetic Drug Production Market Share by Types in 2018
Figure Glimepiride Product Picture
Figure Gliclazide Product Picture
Figure Glyburide Product Picture
Figure Others Product Picture
Table Global Oral Anti-Diabetic Drug Consumption (K Tons) Comparison by Applications (2014-2025)
Figure Global Oral Anti-Diabetic Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Research Institual
Figure Global Oral Anti-Diabetic Drug Revenue (Million USD) (2014-2025)
Figure Global Oral Anti-Diabetic Drug Production (K Tons) (2014-2025)
Figure North America Oral Anti-Diabetic Drug Market Size (Million USD) (2014-2025)
Figure Europe Oral Anti-Diabetic Drug Market Size (Million USD) (2014-2025)
Figure China Oral Anti-Diabetic Drug Market Size (Million USD) (2014-2025)
Figure Japan Oral Anti-Diabetic Drug Market Size (Million USD) (2014-2025)
Table Manufacturing Cost Structure Analysis of Oral Anti-Diabetic Drug in 2018
Figure Manufacturing Process Analysis of Oral Anti-Diabetic Drug
Figure Industry Chain Structure of Oral Anti-Diabetic Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Oral Anti-Diabetic Drug Manufacturing Plants Distribution
Table Oral Anti-Diabetic Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Oral Anti-Diabetic Drug Capacity (K Tons) of Major Manufacturers (2014-2019)
Table Oral Anti-Diabetic Drug Production (K Tons) of Major Manufacturers (2014-2019)
Table Oral Anti-Diabetic Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Oral Anti-Diabetic Drug Production Share by Manufacturers in 2018
Table Oral Anti-Diabetic Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Oral Anti-Diabetic Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Oral Anti-Diabetic Drug Revenue Share by Manufacturers in 2018
Table Oral Anti-Diabetic Drug Average Price (USD/Ton) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Oral Anti-Diabetic Drug Production by Regions 2014-2019 (K Tons)
Table Global Oral Anti-Diabetic Drug Production Market Share by Regions 2014-2019
Figure Global Oral Anti-Diabetic Drug Production Market Share by Regions in 2018
Table Global Oral Anti-Diabetic Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Oral Anti-Diabetic Drug Revenue Market Share by Regions 2014-2019
Figure Global Oral Anti-Diabetic Drug Revenue Market Share by Regions in 2018
Table Global Oral Anti-Diabetic Drug Consumption by Regions 2014-2019 (K Tons)
Table Global Oral Anti-Diabetic Drug Consumption Market Share by Regions 2014-2019
Figure North America Oral Anti-Diabetic Drug Production Growth Rate 2014-2019 (K Tons)
Figure North America Oral Anti-Diabetic Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Oral Anti-Diabetic Drug Production, Consumption Import and Export (K Tons)
Figure Europe Oral Anti-Diabetic Drug Production Growth Rate 2014-2019 (K Tons)
Figure Europe Oral Anti-Diabetic Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Oral Anti-Diabetic Drug Production, Consumption Import and Export (K Tons)
Figure China Oral Anti-Diabetic Drug Production Growth Rate 2014-2019 (K Tons)
Figure China Oral Anti-Diabetic Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Oral Anti-Diabetic Drug Production, Consumption Import and Export (K Tons)
Figure Japan Oral Anti-Diabetic Drug Production Growth Rate 2014-2019 (K Tons)
Figure Japan Oral Anti-Diabetic Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Oral Anti-Diabetic Drug Production, Consumption Import and Export (K Tons)
Figure Global Consumption Oral Anti-Diabetic Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Oral Anti-Diabetic Drug Market Share by Application (2014-2019)
Table Takeda Oral Anti-Diabetic Drug Production Sites and Area Served
Table Takeda Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Takeda Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Takeda Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Takeda Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Takeda Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Takeda Oral Anti-Diabetic Drug Main Business and Markets Served
Table Pfizer Oral Anti-Diabetic Drug Production Sites and Area Served
Table Pfizer Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Pfizer Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Pfizer Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Pfizer Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Pfizer Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Pfizer Oral Anti-Diabetic Drug Main Business and Markets Served
Table Eli Lilly Oral Anti-Diabetic Drug Production Sites and Area Served
Table Eli Lilly Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Eli Lilly Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Eli Lilly Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Eli Lilly Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Eli Lilly Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Eli Lilly Oral Anti-Diabetic Drug Main Business and Markets Served
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production Sites and Area Served
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Janssen Pharmaceuticals Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Main Business and Markets Served
Table Astellas Oral Anti-Diabetic Drug Production Sites and Area Served
Table Astellas Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Astellas Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Astellas Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Astellas Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Astellas Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Astellas Oral Anti-Diabetic Drug Main Business and Markets Served
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Production Sites and Area Served
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Main Business and Markets Served
Table Merck And Co. Oral Anti-Diabetic Drug Production Sites and Area Served
Table Merck And Co. Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Merck And Co. Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Merck And Co. Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Merck And Co. Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Merck And Co. Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Merck And Co. Oral Anti-Diabetic Drug Main Business and Markets Served
Table AstraZeneca Oral Anti-Diabetic Drug Production Sites and Area Served
Table AstraZeneca Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table AstraZeneca Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table AstraZeneca Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table AstraZeneca Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure AstraZeneca Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table AstraZeneca Oral Anti-Diabetic Drug Main Business and Markets Served
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Production Sites and Area Served
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Bristol Myers Squibb Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Main Business and Markets Served
Table Novartis Oral Anti-Diabetic Drug Production Sites and Area Served
Table Novartis Oral Anti-Diabetic Drug Product Introduction, Application and Specification
Table Novartis Oral Anti-Diabetic Drug Production (K Tons), Revenue (Million USD), Ex-factory Price (USD/Ton) and Gross Margin (2014-2019)
Table Novartis Oral Anti-Diabetic Drug Production Growth Rate (2014-2019)
Table Novartis Oral Anti-Diabetic Drug Production Market Share (2014-2019)
Figure Novartis Oral Anti-Diabetic Drug Revenue Market Share (2014-2019)
Table Novartis Oral Anti-Diabetic Drug Main Business and Markets Served
Table Sanofi Oral Anti-Diabetic Drug Production Sites and Area Served
Table Abbott Oral Anti-Diabetic Drug Production Sites and Area Served
Table Biocon Oral Anti-Diabetic Drug Production Sites and Area Served
Figure Global Oral Anti-Diabetic Drug Production (K Tons) Growth Rate Forecast 2019-2025
Figure Global Oral Anti-Diabetic Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Oral Anti-Diabetic Drug Sales Price (USD/Ton) Forecast 2019-2025
Figure North America Oral Anti-Diabetic Drug Production Growth Rate Forecast 2019-2025 (K Tons)
Figure North America Oral Anti-Diabetic Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Oral Anti-Diabetic Drug Production Growth Rate Forecast 2019-2025 (K Tons)
Figure Europe Oral Anti-Diabetic Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Oral Anti-Diabetic Drug Production Growth Rate Forecast 2019-2025 (K Tons)
Figure China Oral Anti-Diabetic Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Oral Anti-Diabetic Drug Production Growth Rate Forecast 2019-2025 (K Tons)
Figure Japan Oral Anti-Diabetic Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Tons) of Oral Anti-Diabetic Drug by Type (2019-2025)
Table Global Consumption (K Tons) of Oral Anti-Diabetic Drug by Application (2019-2025)
Table Oral Anti-Diabetic Drug Distributors List
Table Oral Anti-Diabetic Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources